Emerging evidence suggests that organochlorine, organophosphorus and neonicotinoid insecticide exposure may be linked to the development of obesity and type 2 diabetes. However, there is no knowledge of the potential influence of fipronil, which belongs to the phenylpyrazole chemical family, on obesity. Thus, the goal of this study was to determine the role of fipronil in adipogenesis using 3T3-L1 adipocytes. 
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Introduction
Fipronil (5-amino-1- [2, 6-dichloro-4-(trifluoromethyl) phenyl]-4-[(trifluoromethyl) sulfinyl]-1H-pyrazole-3-carbonitrile) is one of the important broad spectrum insecticides used for the control of arthropod pests, which threaten agricultural yields and the health of humans and other animal species (Dryden et al., 2000) . As a phenylpyrazole compound, fipronil's action is attributable to the potent, antagonistic action at the neurotransmitter gamma-aminobutyric acid (GABA) receptor. In addition, fipronil disrupts the insect nervous system by blocking both GABA-gated chloride and glutamate-gated chloride (GluCl) channels (Raymond-Delpech et al., 2005) . Given that fipronil has a higher binding affinity to insect GABA receptors, and mammals do not have glutamate-gated chloride channels, fipronil has a selective toxicity towards insects compared to mammals (Hainzl and Casida, 1996; Hainzl et al., 1998) .
Fipronil is known to be degraded in the environment through photolysis, oxidation, and reduction. It is reported that fipronil is more susceptible to photolysis (half life, ~8 hr) than hydrolysis (half life, > 100 days) in water at pH 5 (Troung, 2007) . Interestingly, desulfinyl fipronil, a primary photolysis product of fipronil, has approximately 10-fold higher affinity for mammalian GABA receptors than the parent fipronil and substantially reduces selectivity between insects and mammals (Hainzl et al., 1998) . As fipronil has been formulated into a variety of products, such as solid insect baits, liquid sprays, and a granular products, it has been used to control a broad range of arthropod pests, including the boll weevil, grasshoppers, plant hoppers, ants, cockroaches, termites, fleas and ticks (Tingle et al., 2000) . This wide range of usage makes animal and human exposure to fipronil nearly unavoidable and fipronil is categorized as a pesticide of concern for metabolic disorders (Level 3), which needs to be particularly monitored (Bonmatin et al., 2015; Nougadere et al., 2011) . Based on previous M A N U S C R I P T
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4 publications on the relationships between exposure to insecticides and obesity, including our previous reports of other types of insecticides promoting adipogenesis in 3T3-L1 adipocytes (Kim et al., 2014; Kim et al., 2016; Lassiter and Brimijoin, 2008; Lee et al., 2006; Lee et al., 2011; Longnecker and Daniels, 2001; Mangum et al., 2015; Park et al., 2013) , we presently determine the role of fipronil in adipogenesis using the 3T3-L1 adipocyte model.
Materials and Methods
Materials
3T3-L1 preadipocytes were obtained from American Type Culture Collection (Manassas, VA).
Fetal bovine serum (FBS), Dulbecco's modified Eagle's medium (DMEM), methylisobutylxanthin, insulin, dexamethasone, dimethyl sulfoxide (DMSO), 5-aminoimidazole-4-carboxamide ribonucleotide (AICAR), and fipronil were purchased from Sigma-Aldrich Co.
(St. Louis, MO). The contents of triglyceride and protein were quantified using kits from Thermo Scientifics (Middletown, VA) and Bio-Rad Co. (Hercules, CA), respectively. Trizol was bought from Thermo Scientific (Rockford, IL) and other chemicals were purchased from Fisher Scientific (Pittsburgh, PA). Radioimmunoprecipitation assay (RIPA) buffer supplemented with 1% protease inhibitor was purchased from Boston Bioproducts Inc. (Ashland, MA).
3T3-L1 Culture
3T3-L1 preadipocytes were cultured as described in a previous paper (Park et al., 2013) . 3T3-L1 preadipocytes were maintained in DMEM with 10% FBS at 37 °C until confluence. 2 days after confluence (day 0), adipocyte differentiation was induced with DMEM containing 10% FBS and a mixture of methylisobutylxanthin (0.5 mM), dexamethasone (1 µM), and insulin (1 µg/mL). On M A N U S C R I P T A C C E P T E D ACCEPTED MANUSCRIPT 5 day 2, the medium was changed to DMEM containing 10% FBS and insulin only. From day 4, cells were maintained in DMEM plus 10% FBS, and the medium was changed at 2-day intervals.
Cells were treated with fipronil (0.1, 1, and 10 µM) or AICAR (40 µM) from day 0 as indicated in each figure legend. Fipronil (100 mM) and AICAR (0.4 M) stock solutions were prepared in DMSO. Previously, AICAR concentrations at 250 and 1,000 µM were used in 3T3-L1 adipocytes (Habinowski and Witters, 2001) . We tested various concentrations of AICAR (40-500 µM) and determined that 40 µM was appropriate to use without influences on cell viability based on the 3-(4,5-dimethylthiazolyl-2)-2, 5-diphenyltetrazolium bromide (MTT) assay (data not shown) (Mosmann, 1983) . Control was treated with DMSO and all treatments had DMSO at a final concentration of 0.02%. We didn't observe any influences of fipronil concentrations used in the current study on cell viability measured by a MTT based assay method (data not shown).
Triglyceride quantification
Cells were washed with phosphate-buffered saline (PBS) and harvested by scraping in PBS containing 1% Triton-X after 8 days of differentiation. Homogenous samples were obtained from cells by sonication. The amount of triglyceride (TG) in the samples was measured with a commercial assay kit (Infinity™ Triglycerides Reagent; Thermo Scientific) and the protein content was measured with Bio-Rad DC protein assay kit according to manufacturer's instructions. TG content was normalized with protein concentration.
mRNA expression analysis
Trizol reagent was used to extract total RNA from cells under RNase free conditions. Total RNA 
Immunoblotting
Cells were lysed with RIPA buffer supplemented with phosphatase inhibitor cocktail and protease inhibitor cocktail (Thermo Scientific, Rockford, IL). Protein concentrations were determined using the protein DC assay kit (Bio-Rad Co., Hercules, CA). Cell lysates containing 50 µg of protein were separated with 6% or 10 % SDS-polyacrylamide gel and transferred to Immobilin P membrane (Millipore, Bedford, MA). Primary rabbit antibodies were diluted following the recommendation of producers. β-actin was used as an internal control. Horseradish peroxidase conjugated goat anti-rabbit IgG was used as the secondary antibody. Detections were performed on an image Station 4000MM (Carestream Health, New Haven, CT) with Clarity TM Western ECL Substrate Kit (Bio-Rad Co., Hercules, CA). Image and results were quantified with Image J software (Schneider et al., 2012) . Figures 2-4 were analyzed by the one-way analysis of variance procedure (ANOVA) using the Statistical Analysis System (SAS Institute, Cary, NC). Data in Figure 1 were analyzed by the two-way ANOVA with PROC MIXED option. Tukey's multiple-range test was used to determine significant differences between treatments. Significance of differences was defined at the p<0.05 level. Figure 1 shows effects of fipronil on lipid accumulation in 3T3-L1 adipocytes. Fipronil (10 µM) treatment significantly increased TG content compared to control (p<0.001), but not at lower concentrations, in this model.
Statistical analyses
Data in
Results
Fipronil significantly increased lipid accumulation in 3T3-L1 adipocytes
Influence of fipronil on adipogenesis
Figure 2 shows influence of fipronil on genes regulating adipocyte differentiation and lipid metabolism. Treatment with fipronil (10 µM) significantly increased expression of two key genes involved in adipocyte differentiation, CCAAT/enhancer-binding protein α (C/EBPα, p<0.01) and peroxisome-proliferator activated receptor-γ (PPARγ, p<0.0001), compared to control ( Fig. 2A and 2B ). Fipronil (10 µM) also significantly increased expression of two ratelimiting enzymes for lipogenesis, fatty acid synthase (FAS, Fig. 2C ) and acetyl Co-A carboxylase (ACC, Fig. 2D ), compared to control. Expression of fatty acid-binding protein 4 (FABP4), a protein transporting fatty acids in cytoplasm for metabolic process or storage (Terra (Fig. 2E, p<0.0001 ). These results show that fipronil promoted adipocyte differentiation and lipogenesis, contributing to increased lipid accumulation at 10 µM.
Expression of glucose transporter 4 (GLUT4), a 12 trans-membrane protein that plays a major role in insulin mediated glucose transport in adipocytes (Huang and Czech, 2007) , was also significantly increased following 10 µM fipronil treatment compared to control (Fig. 2F,   p<0 .0001). This finding suggests that fipronil may have altered glucose metabolism, which also contributes to increased lipid accumulation in this model. Fipronil treatment, up to 10 µM, did not affect expression of leptin and adipose triglyceride lipase (ATGL) (Fig. 2G and 2H ), which are known to correlate with obesity (Garfinkel et al., 1967 ; Holm et al., 2000) .
Effects of fipronil on the protein expression of regulators for adipogenesis
We further investigated the influence of fipronil on the protein expression of key regulators of adipogenesis (Fig. 3) . Compared to control, fipronil (10 µM) treatment significantly increased the protein expression of C/EBPα (Fig. 3B) and PPARγ (Fig. 3C ). AMPKα is a master regulator of energy production and lipid metabolism in the cell (Park et al., 2002) . Fipronil (10 µM) treatment decreased the phosphorylation of AMPKα significantly compared to control, without affecting the total levels of AMPKα (Fig. 3D, 3E and 3F ). These results indicate reduced activation of AMPKα by fipronil. Expression of ACC (active form), a downstream target of AMPKα, was increased significantly, while phosphorylation of ACC (inactive form) was decreased significantly by fipronil treatment compared to control (Fig. 3G, 3H and 3I ). These 
Effect of AMPKα activation on adipogenesis by fipronil
Next, we investigated whether AMPK activation could inhibit enhanced adipogenesis induced by fipronil using a combination treatment of AICAR, an AMPK activator, and fipronil (Fig. 4) .
AICAR is an adenosine analogue, which is taken up by adenosine transporters on the cell membrane and then is phosphorylated to generate 5-amino-4-imidazolecarboxamide ribotide (ZMP). ZMP mimics AMP, thus, stimulates AMPK phosphorylation in the cell (Merrill et al., 1997) . As shown in Fig. 4 , AICAR treatment alone decreased fat accumulation (p<0.0001 compared to control), while 10 µM fipronil treatment alone significantly increased fat accumulation as observed in results in Fig. 3 . When cells were treated with AICAR and fipronil together, the fat accumulation decreased significantly compared to fipronil treatment alone and control (p<0.0001 for both). Figure 5 shows protein expression of regulators of adipogenesis when AICAR and fipronil were co-treated. As expected, AICAR treatment alone significantly decreased the expression of C/EBPα, ACC, while increased the expressions of pAMPKα and pACC, compared to controls.
Influence of AMPKα activation on protein expression of regulators for adipogenesis
When cells were treated together with fipronil and AICAR, the protein expression of C/EBPα, ACC decreased significantly compared to fipronil treatment alone (p<0.0001 for both). AICAR and fipronil co-treatment also significantly increased the protein expression of pAMPKα, pACC, as well as the ratio of pAMPKα/AMPKα and pACC/ACC (p<0.001), compared to fipronil treatment alone. These results suggest that AMPKα activation could abolish enhanced adipogenesis induced by fipronil.
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Discussion
Results from the current study suggest that fipronil exposure contributes to increased adipogenesis in 3T3-L1 cell model. To our knowledge, this is the first report linking enhanced adipogenesis to fipronil, particularly at 10 µM. We further expand our understanding that AMPKα pathway is involved in increased adipogenesis induced by fipronil.
AMPK is the downstream component of a protein kinase cascade that has a central role in the regulation of energy balance and lipid metabolism (Bijland et al., 2013) . Activation of AMPK has been suggested to inhibit adipogenesis with reduced expression of PPARγ, C/EBPα and late adipogenic markers such as FAS and ACC (Habinowski and Witters, 2001 ). Activation of AMPK has also been reported to inhibit lipogenesis by phosphorylation of ACC, the key regulated step in fatty acid synthesis and fatty acid oxidation. ACC catalyzes the synthesis of malonyl-CoA, a substrate of fatty acid synthesis, and is inhibited by AMPK-mediated phosphorylation of ACC (Daval et al., 2005) . Our current results suggest that fipronil may influence lipid metabolism via post-translational regulation of AMPK. With the current results, it is not clear if fipronil directly or indirectly targets AMPK. However, fipronil has previously been reported to increase intracellular Ca 2+ levels, by alteration of the permeabilization of plasma membrane induced by fipronil (Trump and Berezesky, 1992) . Based on reports that chronic elevation of intracellular calcium might impair the activation of AMPK, via calcium/calmodulin kinase kinase-β (CaMKKβ) (Gormand et al., 2011 ; Park et al., 2009) , it is possible that fipronil may influence intracellular calcium levels and lead to altered adipogenesis and lipid metabolism via CaMKKβ-and AMPK-mediated mechanisms. However, fipronil's effect on intracellular calcium needs to be further confirmed in the future.
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In the current study, no significant differences of leptin mRNA were found between control and fipronil treatment groups in this model. Although we did not measure leptin secretion in this study, it is known that expression of leptin is well correlated to leptin secretion in the 3T3-L1 model (Slieker et al., 1998) . Previously, Lassiter and Brimijoin (Lassiter and Brimijoin, 2008) reported that organophosphorus insecticide treatment could impair leptin production. Two previous publications from our group consistently reported that imidacloprid and permethrin had no effect on leptin expression, which suggests impaired leptin production by these insecticides (Kim et al., 2014 ; Lassiter and Brimijoin, 2008 ; Park et al., 2013) . Thus, the lack of effects of fipronil on leptin expression might be in part due to impaired leptin signaling by fipronil treatment. This may also contribute to altered lipid accumulation, as leptin plays an important role in regulating food intake and glucose metabolism (Morton and Schwartz, 2011) .
The toxicity symptoms of fipronil in mice include hyperactivity, irritability, and convulsions, leading to death (Dobozy, 2000 ; Hamernik, 1997) . Moreover, recently it was suggested that fipronil induces specific liver enzymes, which may have significant implication on interactions with xenobiotics as well as endogenous compounds (Caballero et al., 2015) . The oral LD 50 of fipronil in rat being 97 mg/kg body weight (Dobozy, 2000 ; Hamernik, 1997) . The ADI (acceptable daily intake) of fipronil was determined to be 0.0002 mg/kg body weight, based on the oral NOAEL (no observed adverse effect level) of 0.019 mg/kg body weight/day in a 2-year study of toxicity and carcinogenicity in rats (Dobozy, 2000 ; Hamernik, 1997) . The major metabolite of fipronil detected in adipose tissue, liver, kidney, and muscle of rat was the fipronil sulfone, while two main metabolites, fipronil sulfone and fipronil amide, were found in urine (Dobozy, 2000 ; Hamernik, 1997) . In a pharmacokinetics study of fipronil in rats using 14 Cfipronil administered orally at a single dose of 4 mg/kg body weight, the radioactivity in blood M A N U S C R I P T
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12 reached a maximum value 5.5 hours after treatment and decreased thereafter, with an elimination half-life of 183 hours. The relative long half-life suggests the bioaccumulation of metabolic products from fipronil may have occurred in adipose tissue (Hamernik, 1997) . In fact, the highest concentration of fipronil sulfone in adipose tissue reported was 31 ppm, which is equivalent to ~70 µM (Dobozy, 2000 ; Hamernik, 1997) .
Currently, only limited information exists concerning the serum levels of fipronil in humans. One occupational exposure study of workers at a fipronil production facility reported fipronil sulfone serum level of 17.8 nM, although the levels of fipronil or its metabolites in adipose tissue levels were not measured (Herin et al., 2011) . The plasma levels of total fipronil (including its metabolites) in patients who were orally exposed to fipronil ranged from 0.12 to 9.15 µM (Mohamed et al., 2004) . Thus, levels of fipronil used in the present study were higher than potential exposure levels for most populations. Nevertheless, based on observation that fipronil and its metabolites bioaccumulate in adipose tissue (~70 µM) (Dobozy, 2000 ; Hamernik, 1997) , the findings of the current study may have significant implication on biological relevance of fipronil on adipogenesis.
In comparison to the biological fate of fipronil above, it is also known to be degraded in the environment through photolysis, oxidation, and reduction (Troung, 2007) . Fipronil is particularly sensitive to photolysis with half-life of ~8 hr, resulting in desulfinyl fipronil as the primary photolysis product (Hainzl et al., 1998) . This metabolite has a 10-fold higher affinity for mammalian GABA receptors than parent fipronil and reduces selectivity substantially between insects and mammals (Hainzl et al., 1998) . Thus, it is also important to determine the potential role of metabolites of fipronil from both biological and environmental systems. 
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• Fipronil potentiates lipid accumulation in 3T3-L1 adipocytes
• Fipronil stimulates adipocyte differentiation
• Fipronil enhances adipogenesis via AMP-activated protein kinase-α pathway
